Astex Pharmaceuticals to Present at ASCO Annual Meeting
May 16, 2012 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., May 16, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
Astex Pharmaceuticals Reports 2012 First Quarter Financial Results
April 30, 2012 16:00 ET
|
Astex Pharmaceuticals, Inc.
Reports First Quarter Net Income of $4.2 Million
Dacogen Royalty Revenue Increases 21% from Prior Year
Ends First Quarter with $126 Million in Cash & Marketable Securities
DUBLIN, Calif.,...
Astex Pharmaceuticals to Announce 2012 First Quarter Financial Results on April 30, 2012
April 24, 2012 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., April 24, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
Astex Pharmaceuticals to Present AT26893, a Novel Targeted Approach to the Treatment of HCV at EASL
April 13, 2012 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., April 13, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
Astex Pharmaceuticals to Present at Future Leaders in the Biotech Industry Conference
April 13, 2012 05:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., April 13, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
Astex Pharmaceuticals Announces Subcutaneous SGI-110 Interim Phase 1/2 MDS and AML Data Presentation at AACR
April 03, 2012 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., April 3, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...